Related Experiment Videos
Prenatal cocaine exposure. A longitudinal study of development
1Western Psychiatric Institute & Clinic, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA. gar + @pitt.edu
Insights
Prenatal cocaine exposure impacts infant neurobehavior and later cognitive development, affecting head circumference and intelligence scores by age 3. This study tracked developmental outcomes from birth to 7 years.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- Prenatal substance exposure is a significant concern for child development.
- Cocaine use during pregnancy is associated with various maternal risk factors.
- Understanding long-term effects of prenatal cocaine is crucial for intervention.
Purpose of the Study:
- To investigate the physical, cognitive, and behavioral effects of prenatal cocaine use.
- To assess developmental outcomes at birth, 1, 3, and 7 years.
- To control for confounding factors influencing child development.
Main Methods:
- Longitudinal study design tracking children from birth to 7 years.
- Controlled for maternal sociodemographic factors and substance use (alcohol, marijuana, tobacco).
- Utilized neonatal neurobehavioral assessments and standardized cognitive tests (Stanford-Binet Intelligence Scale).
Main Results:
- Prenatal cocaine use linked to reduced gestational age but not birth weight.
- Neonatal neurobehavioral assessments showed effects of prenatal cocaine exposure.
- At 3 years, prenatal cocaine use predicted smaller head circumference and lower IQ scores.
- Temperamental differences and behavioral problems were observed at 1 and 3 years.
Conclusions:
- Prenatal cocaine exposure is associated with a pattern of central nervous system effects.
- These effects manifest in cognitive and behavioral development up to age 7.
- Findings support the teratologic model of prenatal substance exposure impacts.
Abstract:
The current study examines the effect of prenatal cocaine use on physical, cognitive, and behavioral development at birth, 1, 3, and 7 years, controlling for other factors that affect child development. Women who used cocaine during pregnancy were more likely to be single and to use alcohol, marijuana, and tobacco than were women who did not use cocaine. Prenatal cocaine use was associated with reduced gestational age, but not with birth weight, length, or head circumference. Neonatal neurobehavioral assessments were affected by prenatal cocaine exposure. Growth at 1 year was not affected by prenatal cocaine use. At 3 years, prenatal cocaine use was a significant predictor of head circumference and of the composite score on the Stanford-Binet Intelligence Scale (4th edition). Prenatal cocaine use was also associated with temperamental differences at 1 and 3 years and with behavior problems at 3 years. These findings represent a pattern of central nervous system effects, related to prenatal cocaine exposure, which is predicted by the teratologic model.